Pharmacological interactions between reserpine and orphenadrine. (Record no. 13607115)

MARC details
000 -LEADER
fixed length control field 00814 a2200253 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514123101.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199811s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0004-4172
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name VALDECASAS, F G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19981101
245 00 - TITLE STATEMENT
Title Pharmacological interactions between reserpine and orphenadrine.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Arzneimittel-Forschung
Date of publication, distribution, etc. Apr 1960
300 ## - PHYSICAL DESCRIPTION
Extent 231-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Allergic Agents
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Histamine H1 Antagonists
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Orphenadrine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Parasympatholytics
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reserpine
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name CUENCA, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name MORALES, M
773 0# - HOST ITEM ENTRY
Title Arzneimittel-Forschung
Related parts vol. 10
-- p. 231-4

No items available.